We have developed an analytical, ligand-specific and scalable algorithm that detects a 'signature' of the 3D binding site of a given ligand in a protein 3D structure. The said signature is a 3D motif in the form of an irregular tetrahedron whose vertices represent the backbone or side-chain centroids of the amino acid residues at the binding site that physically interact with the bound ligand atoms. The motif is determined from a set of solved training structures, all of which bind the ligand. Just as alignment of linear amino acid sequences enables one to determine consensus sequences in proteins, the present method allows the determination of three-dimensional consensus structures or 'motifs' in folded proteins. Although such is accomplished by the present method not by alignment of 3D protein structures or parts thereof (e.g., alignment of ligand atoms from different structures) but by nearest-neighbor analysis of ligand atoms in protein-bound forms, the same effect, and thus the same goal, is achieved. We have applied our method to the prediction of GTP-and ATP-binding protein families, namely, the small Ras-type G-protein and ser/thr protein kinase families. Validation tests reveal that the specificity of our method is nearly 100% for both protein families, and a sensitivity of ≥ 60% for the ser/thr protein kinase family and approx. 93% for the small, Rastype G-protein family. Further tests reveal that our algorithm can distinguish effectively between GTP and GTP-like ligands, and between ATP-and ATP-like ligands. The method was applied to a set of predicted (by 123D threading) protein structures from the slime mold (D. dictyostelium) proteome, with promising results.
In part I, the 'binding site consensus motif' -the collection of physical interactions, namely, H-bonds and VDW interactions, between the ligand and its binding site in the receptor protein -of the ligand of interest is first determined from a set of training structures. The training protein structures are first transformed into the 'double-centroid reduced representation' (DCRR). The 3D SM is then derived from the consensus motif. The relation between the usual allatom representation of a protein (as in the PDB) and its corresponding DCRR is shown in Figure 3 . In DCRR, each amino acid residue of the protein is represented by two points: the centroid of its backbone atoms (N, CA, C', O), and the centroid of its side-chain atoms (CB, CG, etc.) , reducing the atomicity of the protein by >76%.
The resulting 3D SM is shown in Figure 4 . The 3D SM is an irregular tetrahedron whose four vertices are the centroids of the backbone and/or side-chain atoms of the residues making the major interactions with the ligand in its binding site (ligand binding site, LBS).
The 3D SM is next validated in par t II using positive and negative control structures. These are, respectively, experimentally solved protein structures which are known to be able to bind, and be unable to bind, the ligand of interest. ROC curves and then plotted to assess the sensitivity and specificity of the procedure using the 3D SM.
Part III is simply the actual application of the method to proteins of unknown function. This involves the screening for the presence of the 3D SM in the test set: the set of experimental or predicted structures of proteins whose functions are being sought, the functional assignment being inferred from the presence or absence of the 3D SM. To implement the algorithm, the four vertices of the tetrahedral 3D SM must be in 'tree' data structure, i.e., exactly one (arbitrarily selected) must be designated as the 'root', and the other three, 'node1 ', 'node2' and 'node3', designated as 'n1', 'n2' and 'n3', respectively (sometimes designated as 'e1', 'e2' and 'e3', respectively, as well) . Our screening algorithm is written in Fortran77 and 90, and requires the parameters of the 3D SM, as input (i.e., the identities of the amino acid residues making up the 3D SM, the lengths of its 6 sides, and the nature of their interaction with the ligand, i.e., via backbone or via side chain, a total of at least 14 parameters). Candidate 3D SM 'sides' are sequestered by the algorithm from the test protein structure 3D structure based on the input parameters as well as the 'connectivity' (i.e., whether each node is connected to the same root, as well as to each other). In ascertaining connectivity, groups of centroids called' clusters' are first selected, from which groups called 'trees' are further selected. An 'error margin', ε, typically ±1.4 Å, is added to the lengths of the sides of the 3D SM to incorporate a fuzzy element into the screening process.
Methods, Procedures and Datasets
Selection of Training Sets. As both GTP-and ATP-binding proteins are both very heterogeneous, we decided to focus on the small, Ras-tywe G-protein and the ser/thr protein kinase families. The training structures for the GTPbinding small, Ras-type G-protein family are shown and described in Table 1 , Panel A. All are small Ras-type Gproteins except 1LOO, which, interestingly, is mouse muscle adenylosuccinate synthetase. The training structures for ATP-binding ser/thr protein kinase family are shown and described in Table 1 , Panel B. All are CDK2, except for 1GOl, which is a MAPK, and 1PHK, 2PHK and 1QL6, which are phosphorylase kinases. All training structures have bound GTP or ATP, and not analogs, since analogs are known sometimes to bind in a novel fashion with the receptor protein (as exemplified by dihydrofolate reductase with bound folate versus methotrexate, see Matthews et al., 1977; Bystroff et al., 1990) .
Determining the 3D Ligand Binding Site Consensus Motif. All calculations and operations were done using Fortran 77 or 90 programs and UNIX scripts. Nearest neighbors of each ligand atom in thet raining proteins in all-atom representation (AAR) are first determined (see Figure 5 ). The H-bonding and VDW interactions were then selected from this set of nearest neighbors. These are tabulated for clarity and ease of analysis by inspection (see Figure 6 ). Those interactions occurring in all or most of the training structures, and/or those with ideal distances between interacting atoms, were selected. The resulting selection is the 3D binding site consensus motif (3D BS CM) for the specific ligand in the protein family under consideration. The H-bonding and VDW interactions in the 3D LBS CM are used to guide the selection of backbone and side chain centroids for inclusion in the 3D SM. The determination of the 3D ligand binding site consensus motif is described in more detail in our previous work (Reyes, V.M. & Sheth, V.N., 2011) .
Building Reduced Representations of Protein Structures in the Training
Set. The protein structures were transformed into DCRR, where each residue is represented by two points: the centroid of the backbone atoms (N, CA, C', O), and the centroid of the side chain atoms (CB, CG, etc.) . DCRR reduces the atomicity of the protein by >76%, making the operations more economical without losing too much chemical information. The conversion of the all-atom PDB representation of the protein into DCRR is described in more detail in our previous work (Reyes, V.M. & Sheth, V.N., 2011) .
Determining the 3D SM. The 3D SM is derived from the 3D LBS CM. The protein file is transformed into DCRR then the nearest neighbors of each ligand atom in the protein are determined. Then the root and nodes of the 3D SM are selected from these nearest neighbor centroids by cross-comparison with the 3D LBS CM (in AAR) determined earlier, based on prevalence and agreement of lengths (H-bonds and VDW interactions) to ideal values (Bondi, et al., J. Phys. Chem., 68:441, 1964) .
Screening for the 3D SM. The screening procedure for the 3D SM has been described schematically in our previous publication (Reyes, V.M. & Sheth, V.N., 2011) . The overall screening algorithm is applied using the 3D SM, which is in double-centroid representation (DCRR; see Figure 7 , Panel A) and is composed of nine steps (see Figure 7 , Panel B), all of which are automated except the last, which is done by inspection. Each of the nine steps is implemented as a Fortran 77/90 program; all are incorporated in a script, allowing the user to perform all nine steps at once, but the last.
Validation Tests. To estimate the sensitivity and specificity of the algorithm for each protein family, positive and negative controls were performed. The positive control structures (n=15) for the GTP-binding small, Ras-type Gprotein family are: 1C1Y, 1GWN, 1NVX, 1PLK, 1QRA, 1ZBD, 3RAP, 521P, 1AS3, 1BOF, 1GIT, 1KAO, 1PLL,  1TAG and 2RAP. They are described in Table 2 , Panel A. The positive control structures (n=15) for the ATP-binding ser/thr protein kinase family are: 1CDK, 1FMO, 1GY3, 1JBP, 1Q24, 1S9I, 1S9J, 1UA2, 2CPK, 1CSN, 1H1W, 1L3R, 1OGU, 1RDQ and 1CM8. They are described in Table 2, Panel B. The negative control structures (n=30) used for all  protein families are: 135L, 1A1M, 1A6T, 1BHC, 1PSN, 1BRF, 1EWK, 1CBN, 1MV5, 1JFF, 104M, 1ASH, 1B3B,  1BRF, 1CKO, 1CRP, 1EWK, 1F3O, 1FW5, 1HWY, 1JBP, 1MJJ, 1MV5, 1NQT, 1OGU, 1PE6, 1RDQ, 1SVS, 1TWY and 1Z3C. They are described in Table 3 . The screening algorithm was performed on both control sets with no distinction between tight and loose binding sites. Specificity (Sp), sensitivity (Sn), success rate (SR) and the Matthews correlation coefficient (MCC) were calculated as follows: Sp = TN/ ( 
Results
Determining the 3D Binding Site Consensus Motif for GTP.
Hydrogen-Bonding Interactions. Based on the protein-ligand H-bonding and VDW interactions common among the training structures, the 3D binding site consensus motif (3D BS CM) is determined. The H-bonding interactions that each GTP atom makes with the amino acid residues at the binding site in the receptor protein in each of the training structures are first tabulated (data not shown). The most common H-bonding interactions shared by members of the training set involve pyrimidine N1 and ring substituents atoms N2 and O6 of GTP. In all cases, pyrimidine N1 and ring substituent N2 atoms are respectively engaged in ideal H-bonds to atoms OE1 and OE2 of an asp residue, while pyrimidine substituent atom O6 is H-bonded to the backbone N of either a lys (one structure) or ala residue (the rest). Interestingly, GTP atoms N1, N2 and O6 are precisely the ones involved in base-pairing interactions involving the guanylate moiety in ribonucleic acids (RNA). Pyrimidine N3 and imidazole nitrogens N7 and N9 do not participate in any H-bonding interactions in all cases. Meanwhile, in structures E, F and P, ribose hydroxyl oxygens O2* and O3* are engaged in ideal H-bonds with backbone oxygens of a his, val or ile residues, and those of a glu or asp residues, respectively, while in structure B, the same ribose oxygens are simultaneously H-bonded to the backbone O of a gly residue. There are no H-bonding interactions involving ribose O2* and O3* in structures M, N and O. Note that we did not consider the binding cavity of the triphosphate moiety of either GTP or ATP because: (1) pyrophosphate sometimes binds proteins nonspecifically; (2) phosphate is a common moiety in biological ligands, and, most importantly; and (3) the triphosphate tail has a high degree of rotational freedom with respect to the guanosine and adenosine moieties (syn and anti conformations), therefore a search motif containing a node or root that corresponds to a triphosphate atom is unlikely to have branches and node-edges that have fixed lengths.
Van der Waals Interactions. As in the previous section, the van der Waals interactions that each GTP atom makes with the amino acid residues at the binding site in the receptor protein in each of the training structures are tabulated (data not shown). For simplicity, VDW interactions involving non-C protein atoms (N, O, P and S) are not considered if they are already involved in H-bonding interaction/s; this approximation is reasonable as, all other things being equal, a H-bonding interaction is about 10 times stronger than a VDW interaction. The most prevalent protein-GTP VDW interactions in family 02B involve three amino acid residues: a lys, a phe and a tyr, but is most pronounced in structures B, F, N and P. Specifically, ribose C1*, and pyrimidine C5 and C6 are all within VDW interacting distance with CE and CG atoms of a lys, while ribose C2* and pyrimidine C4 both lie close to the CZ atom of a phe; finally, ribose C3* and C4* are both close to the CB atom of a tyr. In structure E, ribose C4* and C5* are sufficiently close to atom CB of a pro; in structure O, ribose C2* and imidazole C8 lie close to the CB atom of a thr, as well as CA of a gly in the other; and finally in structure M, ribose C2* and imidazole C8 lie close to the CD and CG atoms, respectively, of two lys residues different from the lys referred to above.
In summary, H-bonding and VDW interactions between GTP and protein prevalent in structures in this family are presented in Figure 8 , Panel A. We note that the binding mode of GTP in this family is characterized by polar interactions between ligand and protein involving the extremities of the guanosine moiety: pyrimidine N1 and substituents N2 and O6 on one end, and ribose O2* and O3* on the other. It as well features non-polar interactions between ligand and protein involving the central portion of the moiety, including the distal edge of the ribose ring composed of atoms C3* and C4*. The four polar atoms in the central part of guanosine -pyrimidine N3, imidazole N7 and N9, and ribose O4* -are not engaged in H-bonding with protein.
Determining the 3D Binding Site Motif Consensus for ATP.
Hydrogen-Bonding Interactions. The procedure was similar to that described for the GTP-binding family the previous section. The most common interactions between ATP and protein are those that involve pyrimidine N1 and pyrimidine substituent N6 of the ligand. In all cases pyrimidine N1 is H-bonded either to a leu or a met backbone N, while pyrimidine N6 is H-bonded to either an asp or a glu backbone O. There is a further pattern: interaction of N1 with a leu and of N6 with an asp are highly correlated; so does the interaction of N1 with a met and N6 with a glu. Interestingly, pyrimidine N1 and N6 are precisely the ones involved in base-pairing interactions involving the adenylate moiety in RNA. On the other hand, pyrimidine N3 and imidazole nitrogens N7 and N9, do not participate in any H-bond interactions. The two ribose hydroxyl oxygens O2* and O3* are also involved in several interactions, notably (a.) between the backbone O of a gln residue and either ribose O2* (structures A, B and E) or O3* (structures G2, I, J1 and J2); (b.) between the OD2 atom of an asp and either ribose O2* (structures D, J1 and J2) or O3* (structure E); (c.) between the OE2 atom of a glu and either ribose O2* (structures I and K) or O3* (structure H); and (d.) between the NZ atom of a lys and ribose O3* (structure D).
Van der Waals Interactions. Again, the procedure was similar to that described for the GTP-binding family the previous section. The most common protein-ATP VDW interactions in members of the ser/thr PK training set are those between (a.) pyrimidine C6 and either the CB atom of an ala or the CD1 atom of a leu; (b.) imidazole C8 and either the CG1 atom of a val or the CD1 atom of a leu, and (c.) ribose C4* and the CA atom of a gly. They occur in all 13 training structures except the last interaction, which is not present in structure D. We note that there are significantly more protein-ATP carbon-carbon VDW interactions in this training set than protein-GTP VDW interactions in the previous 2 training sets. Figure 8 , panel B summarizes the protein-ATP interactions in this training set. We note that binding of ATP is characterized by polar interactions along the extremities of the adenosine moiety, notably involving pyrimidine N1 and N6 on one end and ribose O2* and O3* on the other. Meanwhile, the central part of the moiety is characterized by non-polar interactions, notably ribose C3* and C4*. Of interest is the fact that four polar atoms in the central part of the adenosine moiety -pyrimidine N3, imidazole N7 and N9, and ribose O4* -are not involved in H-bonding.
Deriving the 3D SM for GTP.
Preliminary Considerations. The 3D SM (which is in DCRR) may be considered to be the the distillation of the physical interactions included in the 3D BS CM (which is in ARR), and the 3D SM is essentially a signature of the ligand binding site. During screening, the ligand is conceptually in AAR while the protein is in DCRR. Such a ligand environment composed of centroids does not represent genuine physical interaction, and for clarity we designate it as "association", and reserve the term "interaction" for actual physical interactions as H-bonding and VDW attractive forces. In constructing the 3D SM, the four most prevalent and/or ideal interactions in the training set are selected, and the corresponding centroids are then taken as elements of the 3D SM; these are the protein-ligand associations. In most cases, the best associations are obvious, and it is clear which centroids must be included in the 3D SM. Sometimes, however, there is a 'tie'. In such cases, the root or one or more nodes in the 3D SM is/are not unique and the researcher may incorporate a disjunction ("or") in the 3D SM. Since the protein is in DCRR in the 3D SM, we shall adopt the notation "X(b)" and "Z(s)" to denote "the backbone centroid of amino acid X" and "the side-chain centroid of amino acid Z", respectively. We denote a disjunction by a slash, e.g., L(s)/I(s) means 'leucine side chain or isoleucine side chain' Association Between Protein Backbone Centroids and Ligand Atoms. In all the training structures for this family, ribose O5* is associated with a G(b), while pyrimidine O6 is associated with an A(b) or a G(b). Similarly, pyrimidine N2 is associated with a K(b), and imidazole C8 is associated with a G(b) -the same G(b) associated with ribose O5*. Comparing the above associations against the 3D BS CM, found earlier, we note that ribose O5* is indeed H-bonded to the backbone N of a gly residue in all cases except structure M, while pyrimidine O6 is H-bonded to the backbone N of an ala residue, except again for structure M where it is H-bonded to the backbone N of a lys, and as well to backbones N and O of two different gly residues. In contrast, pyrimidine N2 is not involved in H-bonding, and there is only weak VDW interaction between imidazole C8 and a gly residue. These findings suggest that G(b) and A(b)/G(b), associated respectively with ribose O5* and pyrimidine O6, may be included in the 3D search motif.
Association Between Protein Side-Chain Centroids and Ligand Atoms.
In all the training structures for this family, pyrimidine N1 and ribose O4* are associated with a D(s) and a K(s), respectively. In addition, pyrimidine N3 and C4 are both associated with the same K(s) above. Comparing these associations against the 3D BC CM determined earlier, we note that in all cases except structure E, pyrimidine N1 indeed forms a H-bond with the OD1 and OD2 atoms of an asp residue, while ribose O4* is H-bonded the NZ atom of a lys. Pyrimidine N3, on the other hand, does not participate in any interactions except in structure M, where it is H-bonded to the backbone O of a gly and perhaps as well to the backbone N of a lys. The above information suggest that D(s) and K(s) may be included in the 3D search motif.
Combining the above information with the ones from the previous section, we come up with the 3D SM for this family, see Figure 9 , Panel A. The 3D SM is composed of D(s) as root, A(b)/G(b) as node1, K(s) as node2, and G(b) as node3, which are associated with pyrimidine N1, pyrimidine O6, ribose O4*, and ribose O5*, respectively, of GTP. The lengths of the three branches (Rn1, Rn2 and Rn3) and three node-edges (n1n2, n1n3 and n2n3) complete the 3D SM; each is the averages from all the training structures. In most cases, the standard deviations are less than 1.0 Å, the rest being not much greater than 1.0 Å.
Deriving the 3D SM for ATP.
Association Between Protein Backbone Centroids and Ligand Atoms. In all the training structures for this family, we readily observe the following associations: (a.) pyrimidine N6 with a E(b) or an D(b), (b.) pyrimidine N1 with a L(b) or a M(b), (c.) imidazole N7 with an A(b), (d.) ribose O3* with either a E(B) or a Q(b) (except for structure G2), (e.) ribose O4* with a G(b), and (f.) pyrimidine C2 and C6 both with a L(b) or a M(b). Comparing the above associations against the 3D BS CM for this family found earlier, indeed we find that pyrimidine N6 is H-bonded to the backbone O of either a glu or an asp, validating (a.) above. Similarly, pyrimidine N1 is H-bonded to the backbone N of a leu or a met, thus validating (b.) above. In contrast, imidazole N7 is not involved in H-bonding, so (c.) above cannot be validated. The case for ribose O3* is not strong, as it is not H-bonded to a glu or a gln backbone O or N in 5 of the 13 training structures; we thus rule out (d.) as well. Cases (e.) and (f.) above are similarly weak. These findings suggest that E(b)/D(b) and L(b)/M(b), associated respectively with pyrimidine N6 and N1, may be included in the 3D search motif.
Association Between Protein Side-Chain Centroids and Ligand Atoms.
In all the training structures for this family, we readily observe the following associations: (a.) ribose O2* with an D(s) or a E(s), (b.) pyrimidine N1 and N6 both with an A(s), (c.) ribose O4* with either a V(s) or a G(s), (d.) imidazole C8 with a V(s), and (e.) pyrimidine C5 and C6 both with an A(s). Again, comparing the above associations against the 3D BS CM for this family found earlier, we note that ribose O2* is indeed H-bonded to the OD2 or the OE2 atom of an asp or a glu, respectively, in all cases except structures C2 and G2, validating association (a.) above. In contrast, neither pyrimidine N1 nor N6 is H-bonded with an ala in any of the 13 training structures, ruling out (b.) above. Meanwhile, ribose O4* is in H-bonding interaction in only 3 of the 13 training structures, and never with a val; thus (c.) above may be eliminated. Except for structure D, imidazole C8 is always in VDW interaction with a val, thus validating (d.) above. Finally, pyrimidine C5 and C6 are only weakly involved in VDW interaction with an ala, hence (e.) is eliminated. The above findings indicate that we may include D(s)/E(s) and V(s), which are associated with ribose O2* and imidazole C8 respectively, in the 3D search motif for this family.
Combining the above results with those from the previous section yields the four centroids comprising the 3D SM for this family, see Figure 9 , Panel B. The 3D SM is composed of E(b)/D(b) as root, V(s) as node1, D(s)/E(s) as node2 and L(b)/M(b) as node3, which are associated with pyrimidine N6 and N1, ribose O2* and imidazole C8, respectively, of ATP. The lengths of the three branches (Rn1, Rn2 and Rn3) and three node-edges (n1n2, n1n3 and n2n3) complete the 3D SM; as before, each is the averages from all the training structures. In most cases, the standard deviations are less than 1.0 Å, the rest being not much greater than 1.0 Å
The Control Experiments.
Ideally, the positive control structures should be structures which are known to contain the particular 3D SM; similarly, negative controls must be structures which are known to not contain the 3D SM. Since there is no practical way of determining the existence of the 3D SM's in protein 3D structures except by visual examination, we simply chose positive controls from the PDB by their similarity to the training structures, and negative controls by their dissimilarity with the training structures. Thus the results of the control tests presented below must be interpreted with caution.
Validation Tests for the Small Ras-type G-protein Family.
Fourteen out of the 15 positive controls tested positive under the screening algorithm, while all 30 negative controls tested negative. Thus there are 14 true positives, 1 false negative, 30 true negatives, and 0 false positive. This suggests that, for this family, our algorithm has a sensitivity of 93.3%, a specificity of 100.0%, a success rate of 97.8%, and a Matthews correlation coefficient of 95.0%.
Validation Tests for the ser/thr PK Family. Nine out of the 15 positive controls tested positive under our algorithm, while all of the 30 negative controls tested negative. Thus there are 9 true positives, 6 false negatives, 30 true negatives, and 0 false positives. This suggests that, for this family, our algorithm has a sensitivity of 60.0%, a specificity of 100.0%, a success rate of 86.7%, and a Matthews correlation coefficient of 70.7%.
ROC Curves. Partial ROC curves constructed from the above results using the fact that ROC curves are parabolas that pass through the points (0,0) and (1,1) are shown in Figure 10 , Panels A (left) and B (right) respectively, for the GTP-binding small, Ras-type G-proteins and the ser/thr protein kinase families.
Expanded Test Sets for the GTP-and ATP-binding families.
To further ascertain the sensitivity of our algorithm to the detection of the GTP-and ATP-binding sites in the two protein families, we tested more positive structures for both families using our screening algorithm. The expanded test set (positive structures, n=45) for the Ras-type GP family are: 1A2B, 1A2K, 1CTQ, 1FZQ, 1GG2, 1GP2, 1GUA, 1HUQ, 1JAH, 1JAI, 1K5D, 1K5G, 1KAO, 1MH1, 1N6L, 1NVU, 1NVV, 1NVW, 1OIV, 1OIW, 1OIX, 1QRA, 1R2Q, 1R4A, 1RYF, 1RYH, 1T91, 1WA5, 1WQ1, 1YHN, 1YZT, 1YZU, 1Z08, 1Z0A, 1Z0D, 1Z0J, 1ZBD, 1ZC3, 1ZC4, 2BKU, 2EW1, 2RAP, 3RAB, 3RAP and 5P21. They were selected from the PDB by keyword search, "Ras-type Gprotein." Using the algorithm to screen them for the 3D SM of the GTP-binding site in the small, Ras-type Gproteins, all tested positive. These results indicate that the algorithm has high sensitivity for this family (see Figure  11 , Panel A).
The expanded test set (positive structures, n=31) for the ATP-binding ser/thr PK family are: 1BO1, 1IA9, 1E8X, 1CJA, 1NW1, 1J7U, 1CDK, 1O6L, 1OMW, 1H1W, 1MUO, 1TKI, 1JKL, 1A06, 1PHK, 1KWP, 1IA8, 1GNG, 1HCK, 1JNK, 1HOW, 1LP4, 1F3M, 1O6Y, 1CSN, 1B6C, 2SRC, 1LUF, 1IR3, 1M14 and 1GJO. They are the 31 representative protein kinase structures used in the paper by Scheeff and Bourne (PLOS CB, 2005) . Using the algorithm to screen them for the 3D SM of the ATP-binding site in the ser/thr protein kinase family, all but two tested positive. The two which tested negative were 1CJA and 1NW1, which were classified by Scheeff & Bourne to be "atypical protein kinases" due to the atypical architecture of their ATP binding sites. These results indicate that the algorithm has high sensitivity for this family (see Figure 11 , Panel B).
Additional Tests to Assess Discriminatory Power of Algorithm.

Screening of Proteins Binding GTP-like Ligands:
To ascertain the ability of our method to distinguish between GTP and GTP-like ligands, the following proteins that bind GTP-like ligands were randomly selected from the PDB: a GDP-binding protein (1kv3), a GMP-binding protein (1znx) and a cyclic GMP-binding protein (1q3e). Each were then screened using the search motif derived from the small Ras-type G-protein family (02B), initially with ε= 1.00 Å. All three structures tested negative, being eliminated early on in the screening process. A second screening with a more relaxed ε= 1.40 Å similarly produced negative results from all three structures. These results suggest that the ligand binding sites of these proteins are quite different from that of family 02B, and that our algorithm can effectively differentiate between them.
Screening of Proteins Binding ATP-like Ligands:
To ascertain the ability of our method to distinguish between ATP and ATP-like ligands, the following proteins that bind ATP-like ligands were randomly selected from the PDB: a SAH-binding protein (10mh), a NAD-binding protein (1axe) an ADP-(and FAD-) binding protein (1cnf), an FADbinding protein (1jrx), an AMP-(and FAD-) binding protein (1t9g), and a cAMP-binding protein (1ykd). Each were then screened using the search motif derived from the ser/thr PK protein family (01a), initially with ε= 1.00 Å. Five of the six structures yielded negative results, while structure 1jrx gave a positive result. Upon closer inspection, however, the putative ATP-binding site signature detected by the algorithm in structure 1jrx (namely, Asp-513, Val-539, Asp-358 and Met-511) turned out to be a spurious motif that is about 15 Å away from the genuine FAD binding site. This motif, although apparently resembling the ser/thr PK search motif, most probably does not have biological significance and occurred by chance. A second screening with a more relaxed ε= 1.40 Å again produced negative results from the same 5 of the 6 structures as before, but picked up a new putative ATP binding site signature in structure 1jrx. Upon closer inspection, this second ATP-binding site (namely, was indeed located approximately where the adenosine moiety of FAD is bound in the protein (data not shown). However, the interaction of the residues in the search motif with the FAD adenosine moiety was only partial: that is, although carboxyl atoms OE1 and OE2 of Glu-156 (the root) are ideally H-bonded to the ribose hydroxyls AO3* and AO2* of the FAD adenosine moiety (at 2.67 Å and 2.51 Å, respectively), atom CG1 of Val-294 (node 1) is in VDW interaction not with FAD adenosine AC8 but with AN1, and the interaction is weak (at 6.97 Å); atom C of Leu-154 (node 3) is in VDW interaction not with FAD adenosine AN1 but with AC2, and the interaction is even weaker (at 7.74 Å); and Asp-125 (node 2) is not in H-bonding at all with any FAD adenosine atom. Taken together, these results demonstrate that our algorithm can effectively differentiate the ATP-binding site of the ser/thr PK family from the ATP-like ligand binding sites of the above proteins.
Comparison of Method with Global Structure-Based Methods.
To demonstrate that the present method, which is local structure-based, works where global structure-based methods do not, consider the set of ATP-binding proteins with differing global folds but with similar ATP-binding site architectures, compiled by Kobayashi & Go (1997a; 1997b) . Using the 4 ATP-containing structures in the set -1cdk, 2dln, 1csn and 1gsa -for training, the ATP-binding site consensus motif determined from them yields the following 3D search motif:
; length Rn1 = 6.152; length Rn2 = 7.731; length Rn3 = 10.334; length n1n2 = 7.765; length n1n3 = 13.894; and length n2n3 = 10.279; with ε = 1.00 Å}. This search motif was used to screen the other 8 structures in the group -2glt, 1scub, 1bnc, 1irk, 1dik, 1gtr, 1ses and 1lgr. All 8 tested positive (data not shown). This confirms that our algorithm can pick up all of these structures despite the fact that they have differing overall global folds. When the four training structures were inputted into the fold-based method, DALI, only training structures 2dln and 1gsa were able to pick up structures in the test set: 1bnc and 1dik. Even so, the ranks were low (2dln picked up 1bnc with rank 5, and 1dik with rank 12; 1gsa picked up 1bnc with rank 7, and 1dik with rank 14) and the RMSD's were high (2dln picked up 1bnc with RMSD of 6.0Å, and 1dik with RMSD of 3.1Å; 1gsa picked up 1bnc with RMSD of 5.4Å, and 1dik with RMSD of 3.7Å). The other two training structures (1cdk and 1csn) did not pick up any structure from the test set. Thus six of the eight test structures were invisible to DALI. The above results demonstrate that the present algorithm, being local-structure-based, is able to assign function to proteins where global fold-based methods such as DALI fail.
Benchmark Experiment: Use of Predicted Structures. We applied our method to the newly-sequenced proteome of the slime mold, Dictyostelium discoideum (Eichinger et al., 2005) . A subset of the slime mold proteome was used to build 3D structures models of proteins from primary sequence using the threading program, 123D (Alexandrov et al., 1995) , and the side chain modeling and partial refinement program, Modeller 6.2 (Sali et al., 1993) . We selected proteins which did not have functional annotation at the time. The resulting protein models, 400 in all, were screened using the 3D SM for the two protein families. 47 structures tested positive for the Ras-type G-protein family, of which 10 have 'tight' binding sites (ε ≤ 1.0 Å), and 37 have 'loose' binding sites (1.0 Å ≤ ε ≤ 2.0 Å). Meanwhile, 52 structures tested positive for the ser/thr protein kinase family, of which 46 have 'tight' binding sites, and 6 have 'loose' binding sites (data not shown). These sets of structures have common elements. Preliminary independent results support the above findings. Most notably, a Dictyostelium protein containing the FNIP domain (marked by phe-asn-ile-phe repeats), which is of unknown function and occurring exclusively in amoeboid proteomes, has been found to possess the GTP binding site using our algorithm. Thus, our method seems to hold promise for function prediction using predicted structures, instead of experimentally solved structures.
Discussion
Salient Features of the Method. In the following sections, we discuss the salient features of our method and try to relate them to existing methods that have the same objective of predicting functional sites in protein 3D structures.
Ability to Detect Consensus Binding Sites in Proteins of Different Folds.
From the foregoing sections, it is obvious that the present method achieves the detection of three-dimensional motifs in the binding sites of 3D protein structures by nearest-neighbor analysis of the bound ligand, and not by C-α alignment of protein structures. Such is an important consideration because it is known that proteins of different folds -which are not C-α alignable -can and do bind the same ligand using the same 3D binding site consensus. This is one strength of the present method.
Inherent Objectivity. The 3D SM in our method is based purely on protein-ligand H-bond and VDW interactionsinformation that is completely derivable from the PDB file. Similar existing methods involve construction of 'templates' based on catalytic site residues, determined with unavoidable subjective input from the experimenter and derived by human perusal of the literature. The fact that our approach is based on binding residues instead of catalytic residues means it is more objective than other similar methods.
Ligand Specificity. Other existing methods of functional site prediction involves merely specifying local sections of the protein 3D structural surface that are biologically important, without providing information exactly what the local site does -e.g., is it a catalytic site? is it a ligand binding site, and if so, what specific ligand does it bind? is it involved in protein-protein interaction, and if so, what is the partner protein?. In contrast, our method is ligandspecific: the researcher decides on the specific ligand for study, then collects a set of training structures from the PDB containing that ligand. Such ligand-specificity makes functional assignment more straightforward and objective.
Extensibility and Scalability. Our method is amenable to automation and thus well-suited for large-scale function assignment to entire proteomes. Other methods involve molecular dynamics simulations, and hence not easily automatable. Here, our method is applied to ATP and GTP binding site prediction, but it is also applicable to other ligands. Recently we have used it to predict sialic acid, retinoic acid, and heme-bound and unbound nitric oxide binding sites in experimentally solved protein structures in the PDB that currently do not have functional annotation (Reyes, V.M., unpublished [a.] ). We have also extended the method to the prediction of specific protein-protein interaction partners (Reyes, V.M., unpublished [b.] ). These applications demonstrate the extensibility and the versatility of the method. Additionally, the present method can be applied to non-protein structures, such as carbohydrate and lipid structures, which do not possess "standard" monomers (e.g., amino acids).
Analytical Nature. Other methods of protein functional site prediction make use of traditional machine learning techniques such as SVM, etc. Being statistical in nature, these methods do not allow the researcher full control over the classification process and involves some inexactitude in the results. In contrast, our algorithm is analytical, and as such it is one of only a handful of deterministic methods of functional site prediction currently available.
Local Structure Dependence. Our algorithm is designed to detect protein 'local structures' -the constellation of amino acid residues that come together in 3D space when the protein folds to assume its 3D structure (see Figure 1) . The 3D SM defined in this work is precisely such a constellation of residues in space; our algorithm detects this spatial arrangement of residues in the input structure. A key concept here is that proper folding of the protein into its correct 3D structure is a prerequisite to the correct assembly of local structure.
Use of Novel 'Tree' Data Structure. To implement our algorithm, the 3D SM must be in 'tree' data structure, composed of a unique root, and typically 3 nodes, which together form an irregular tetrahedron. The qualitative and quantitative input parameters of the algorithm are all embodied in the 3D SM -the amino acid identities of the root and nodes, their interaction type (side chain or backbone), and the lengths of the 6 edges of the tetrahedron. The lengths of the 6 edges are determined by direct calculation from the atomic coordinates. Thus the optimal input parameter values are essentially dictated by the ligand's molecular dimensions. Although in theory the search motif can have 2 or more than 3 nodes, pilot tests demonstrate that a search motif composed of exactly 4 centroids (1 root and 3 nodes) has sufficient sensitivity and specificity to detect genuine ligand binding sites. Including even one more node results in a steep increase in computation time but little improvement in accuracy. Thus in this work we use search motifs composed of exactly 1 root and 3 nodes.
Consideration of H-Bond and VDW Interactions Between Protein and Ligand.
Our method takes into account both H-bonds and VDW interactions in building the 3D SM. Other methods consider only polar interactions (i.e., H-bonds) between ligand and protein. However, ligand stabilization at the active site does not depend solely on H-bonding interactions; VDW attractive forces also play a significant role. Although a typical H-bond (2 -10 kcal/mol) is about 10 times stronger than a typical VDW attractive force (0.1 to 1.1 kcal/mol), in our protein-ligand systems (ligand = ATP or GTP), there are approximately 8-9 VDW attractive forces per H-bond. It may thus be concluded that the contributions of H-bonding and VDW attractive force to ligand stabilization at the binding site are roughly of the same order of magnitude. This is most likely to be true in general.
Use of Double Centroid Residue Reduced Representation.
Other methods use CA atoms to represent amino acid residues; this is not ideal, as it results in significant loss of information (see next section). Our method makes use of the 'double centroid residue representation' during screening for the ligand binding site. In DCRR, each protein residue is represented by two points: the centroid of its backbone atoms (N, CA, C' O), and the centroid of its side chain atoms (CB, CG, etc.,) . Although the protein's atomicity is reduced by >76% compared to >88% using CA atoms, it is more than compensated for by the greater resolution and accuracy achieved (see below). A DCRR-like representation has been used before (Kleywegt, 1999) , but unbeknownst to the author during the early stages of this study. Use of reduced protein representations such as DCRR also adds a fuzzy element into the screening process, thus counteracting the inherent uncertainty in screening predicted structures. Even in instances where the input structures are experimental or predicted with high accuracy, use of DCRR minimizes uncertainties resulting from protein dynamics and flexibility.
Consideration of Both Protein Side Chain and Backbone
Interactions. Just as consideration of protein global fold alone is insufficient in predicting protein function, consideration of primary sequence alone is also ineffective. First, to consider sequence alone means to neglect protein folding altogether. During protein folding, often residues that are nonconsecutive and/or separated by any number of residues in the primary sequence come together in 3D space to form the local structure. Second, the backbone N-H and/or C=O of one or more binding residues are commonly involved in H-bonding with certain ligand atoms. This enables their corresponding side chains to almost freely assume any identity, thus allowing a high degree of sequence variation at these sites. Our method gives equal consideration to both backbone-ligand and side chain-ligand interactions. About 40% of all protein-ligand H-bonds in the training structures involve the protein N or O backbone atoms, while the rest involve side-chain functional groups; it is thus clear that protein backbone-ligand and protein side chain-ligand interactions both contribute significantly to the stabilization of the bound ligand.
Use of Fuzzy Additive Term. Our method incorporates am error margin, ±ε, as an element of "fuzziness" to the screening process that is meant to minimize and/or counteract the inherent uncertainty in predicted structures and/or counteract the effects of protein flexibility.
Semi-Docking Nature of Method. Our method may be considered a semi-docking procedure. This is because not only is the precise geometry of the 3D SM known, but also the identity of its root and nodes. Thus the algorithm can search for the specific amino acids and their mode of interaction with the ligand (via backbone or side chain). Similarly, the specific ligand atoms interacting with the root and nodes are also precisely known. Thus the precise orientation of the ligand relative to its binding site in the protein is precisely determined. This is an advantage over existing methods which simply identify the location of functional sites.
Limitations of the Method.
First, we have currently no provision to automatically (computationally) ascertain the relative location of the detected 3D SM in the protein, i.e., whether it is located on the surface, lodged in a deep crevice, or close to the protein centroid. To this end, we have recently developed two complementary algorithms to quantify the degree of burial of ligand binding sites in proteins called the 'cutting plane' and 'tangent sphere' methods (V. M. Reyes, unpublished [c.] ). Second, the error margin, ε, incorporated into the branch and node-edge lengths is usually in the order of 1.0 -1.5 Å. Thus in cases where the protein assumes drastic conformational changes upon ligand binding, our method might fail. Third, in the determination of H-bonds between protein and ligand, we do not ascertain the linearity of the bonds of the interacting atoms -we merely measure non-hydrogen interatomic distances. However this issue is unlikely to have a significant effect on our results, as we sequester only those with perfect or near-perfect H-bond distances (2.7Å-2.9 Å). Cases in which the H-bonding atoms have perfect or near-prefect H-bonding distances and at the same time non-linear, are quite rare. The basic underlying idea behind much of the rationale for the work presented here is shown. The ligand binding site, a local structure, is formed by the coming together in 3D space of residues usually far apart and in no particular sequence in the protein primary sequence. The ligand binding residues may be conserved to varying degrees, as the interaction with ligand may be via side-chain or via backbone. Thus, ligand binding sites are created from primary structure through protein folding. This requirement for precise protein folding in the creation of such biologically important local structures is a major reason why they are more effective in assigning function to proteins than primary sequence (no protein folding) and overall global fold (imprecise protein folding and neglect of side chains). The overall methodology may be regarded as being composed of two parts: Part I: the 3D motif consensus and search motif determination (left half), and Part II: the actual application of the screening procedure itself to an application/test set (right half), taking information 'learned' from (Part I). In this diagram, the test/application set in (Part II) is depicted as having been predicted from threading (123D) and modeling (Modeller6v2) as in the present work, but they may also be experimentally solved structures, e.g., from X-ray crystallography and protein NMR. (CB, etc.) , the centroid of each group computed, and the residue represented by the two centroids. An artificial ligand is shown interacting with residues at its binding site; the interactions in the all-atom representation are H-bonds and VDW attractive forces; in DCRR, they are non-physical interactions, and we call them 'associations.' Figure 4 . General Structure of the 3D Search Motif. The general structure of the 3D search motif is an irregular tetrahedron, with one corner designated as the 'root', R, and three others, the three 'nodes', n1, n2 and n3. As such it is also called a 'tree' data structure. Higher-order irregular polyhedra such as a pentahedron, etc., are possible, but not as computationally efficient for use as a tetrahedron (see text). Edges emanating from the root are called 'branches', while those that join two nodes are designated 'node-edges.' The root and nodes represent amino acid residue centroids (backbone or side chain) in association with ligand atoms. A table is constructed with the training structures as the columns and each ligand atom as the rows; in the figure is a theoretical ligand with 12 atoms, and there are 10 protein structures in the training set. Each cell in the table contains all possible H-bond and VDW pairs between the ligand atoms and amino acid atoms in the binding site of the particular training structure. Those which recur with greatest frequency among the training structures are encircled: red for ligand atom 2, green ligand atom 5, blue for ligand atom 8 and purple for ligand atom 12. These four ligand atoms are then taken to be the 3D binding site motif consensus for this specific ligand; since there are four of them in 3D space, they form a tetrahedron. Figure 7 (A, B) . The Search Algorithm Illustrated for a Theoretical Ligand and its Protein Receptor. Panel A shows a theoretical 3D SM with nodes of the tree-structured 3D motif labeled (one root and three branch nodes, branches and node-edges), as well and theoretical distances between each nodes and the fuzzy additive term, ϵ. Panel B shows the 3D SM search algorithm in finer detail. The boxed items in green are Fortran programs (namely, 2, 3a, 3b, 5, 6, 8, 10, 12 and 13 ) that take input(s) and produce output(s), as indicated by the arrows, and appropriately labeled. Note that the very first input is the protein structure in all-atom representation (AAR), and the very final output is the 3D SM. The eight programs (excluding 13, which is currently done by inspection) have been incorporated together into one script and may be executed in one keystroke. Figure 8 (A, B) . The 3D Binding Site Motif Consensus for the GTP-and ATP-binding Families. The 3D binding site consensus motif for GTP in the small, Ras-type G-protein family (Panel A), and for ATP in the ser/thr protein kinase family (Panel B) are shown. The triphosphate portion of either ligand is not shown in full, as it is disregarded in determining the consensus (as well as in building the 3D search motif). The protein residues engaged in these interactions are drawn in short-hand notation, i.e., two perpendicular arrows intersecting at the midpoint of one (the backbone part) and at the endpoint of the other (the side chain part), which we call the 'backbone arrow' and 'side chain arrow', respectively. The arrowhead of the backbone arrow represents the backbone carbonyl oxygen, its midpoint the C-α atom and its endpoint the backbone amide nitrogen. The arrowhead of the side chain arrow represents either the H-bonding or the terminal atom in the side chain, as the case may be. The one-letter designations of the amino acid residues are indicated; the forward slashes indicate disjunction ("or"). The red dashed lines are Hbonds, and the blue ones VDW interactions, between protein and ligand atoms. Figure 9 (A, B) . The 3D Search Motifs for the GTP-and ATP-binding Families. The 3D search motifs derived from their respective consensus motifs are shown for the GTP-binding families, small Ras-type G-proteins (Panel A) and mRNA capping enzymes (Panel B), and the ATP-binding family ser/thr protein kinases (Panel C). The ligands are shown with their standard atom designations, except for the triphosphate tail, only whose location is shown. The root and three nodes of the search motifs are indicated as R, n1, n2 and n3, respectively. Shown also are the one-letter designations of the amino acid residues in association with the ligand atoms, the qualitative input parameters of the algorithm. Each is shown in DCRR as an arrowhead connected by a dashed line to a circle; the former represents the residue's side chain centroid, while the latter, the residue's backbone centroid. The lengths of the six sides of the search motif (tetrahedron), which are the quantitative input parameters of the screening algorithm, are shown in the small table at the bottom right of the figure. 
